Navigation Links
Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area
Date:6/25/2008

Award Recognizes Entrepreneurial Excellence in Emerging Category

LOS ANGELES, June 25 /PRNewswire/ -- Agensys, Inc. a biotechnology company, today announced that Dr. Donald Rice, Founder, President, & CEO, received the Ernst & Young Entrepreneur Of The Year(R) 2008 Award in the Emerging category in the Greater Los Angeles Area. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. Dr. Donald Rice was selected by an independent panel of judges, and the award was presented at a gala event at the Beverly Hilton Hotel on June 24, 2008.

"This award belongs to the entire Agensys team, a small group that built an integrated biotech company that has so far brought forward 5 novel products that will help many cancer patients in the future," said Dr. Rice. "Helping cancer sufferers will be the ultimate reward."

Agensys develops monoclonal antibodies to its own novel targets to treat a variety of human cancers. After 10 years as a private company, the entire Agensys team was acquired by Astellas Pharma, Inc., the second largest Japanese pharmaceutical company, in December, 2007. It operates today as a separate subsidiary of the parent, with Dr. Rice as President and CEO.

The Ernst & Young Entrepreneur Of The Year awards celebrate their 22nd anniversary this year. The program honors entrepreneurs who have demonstrated exceptionality in such areas as innovation, financial performance and personal commitment to their businesses and communities.

"Ernst & Young is pleased to honor outstanding business leaders such as Dr. Donald Rice," said Brian Ring, Ernst & Young Entrepreneur Of The Year Program Director for the Greater Los Angeles Area. "Winners of the Entrepreneur Of The Year award build leading businesses and contribute a great deal to the communities around them. Their success helps our area grow stronger."

As a Greater Los Angeles Area award winner, Dr. Donald Rice is now eligible for consideration for the Ernst & Young Entrepreneur Of The Year 2008 national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 15, 2008. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies.

Sponsors

Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors.

In the Greater Los Angeles Area, local sponsors include Marsh, Scherzer International, City National Bank and Bowne.

About the Ernst & Young Entrepreneur Of The Year Awards

Ernst & Young's Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

About Ernst & Young

Ernst & Young is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 130,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve potential.

For more information, please visit http://www.ey.com.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.

This news release has been issued by Ernst & Young LLP, a member firm of Ernst & Young Global Limited.

Contact: Tracy M. Dolan, Agensys, Inc., 310.820.8029 x211, tdolan@agensys.com


'/>"/>
SOURCE Agensys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
2. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
3. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
4. Stereotaxis Appoints Senior Vice President, North America
5. Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors
6. Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
7. Orchid Cellmark Appoints Jeffrey S. Boschwitz as Vice President, North America Marketing & Sales
8. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
9. Kendle Appoints Patricia Williams Vice President, Commercial Operations
10. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
11. Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... , Nov. 30, 2016 /PRNewswire/ - Portage Biotech ... Securities Exchange: PBT.U), is excited to announce the ... focused on developing preclinical ophthalmology assets through proof ... potent anti-inflammatory created by Portage Pharmaceuticals Limited and ... with ocular surface and anterior segment diseases. This ...
(Date:11/30/2016)... -- The Allen Institute for Cell Science has released ... collection of gene edited, fluorescently tagged human induced ... with unprecedented clarity. Distributed through the Coriell Institute ... crucial first step toward visualizing the dynamic organization ... cells healthy and what goes wrong in disease. ...
(Date:11/30/2016)... 2016  Tempus, a technology company focused on ... Abramson Cancer Center have partnered to better determine ... immunotherapy treatment based on next generation genomic and ... a research collaboration, Tempus will provide sequencing and ... data to Penn. Utilizing next-generation sequencing, machine learning ...
(Date:11/30/2016)... , 30. November 2016   Merck ... heute die Unterzeichnung einer Reihe von Vereinbarungen ... wird Evotec AG Screeningleistungen für Mercks Palette ... Der Zugriff auf diese Bibliotheken in Kombination ... einen schnelleren Weg zur Ermittlung und Erforschung ...
Breaking Biology Technology:
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
(Date:11/16/2016)... Sensory Inc ., a Silicon ... consumer electronics, and VeriTran , a technology ... today announced a global partnership that will provide ... users of mobile banking and mobile payments solutions.  ... which requires no specialized biometric scanners, yet provides ...
Breaking Biology News(10 mins):